Science Pool

Evotec expands clinical and commercial drug substance manufacturing with acquisition of Central Glass Germany

Evotec SE announced today that the Company expands its clinical and commercial manufacturing platform for small molecule therapeutics by acquiring Central Glass Germany GmbH from the Japanese chemical manufacturing company Central Glass Co. Ltd.

Read More

Twitter
LinkedIn
Email
Generated by Feedzy